Profiel
Paul Schaffer currently works at Telix Pharmaceuticals Ltd., as Chief Technology Officer from 2025.
Dr. Schaffer also formerly worked at Centre For Probe Development & Commercialization, as Director from 2018 to 2021 and ARTMS, Inc., as Chief Technology Officer from 2018 to 2025.
Actieve functies van Paul Schaffer
| Bedrijven | Functie | Begin |
|---|---|---|
| TELIX PHARMACEUTICALS LIMITED | Hoofd Techniek/Wetenschap/O&O | 07-04-2025 |
Eerdere bekende functies van Paul Schaffer
| Bedrijven | Functie | Einde |
|---|---|---|
ARTMS, Inc.
ARTMS, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Algemeen Directeur | 28-03-2018 |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes radiopharmaceuticals for early diagnosis and treatment of diseases | Directeur/Bestuurslid | 17-06-2021 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Telix Pharmaceuticals Ltd.
Telix Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals | Health Technology |
ARTMS, Inc.
ARTMS, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes radiopharmaceuticals for early diagnosis and treatment of diseases | Health Technology |
















